We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-1.69%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$544B
AUM Growth
+$2.89B
Cap. Flow
+$24.2B
Cap. Flow %
4.45%
Top 10 Hldgs %
14.36%
Holding
11,092
New
1,200
Increased
4,608
Reduced
3,996
Closed
929

Top Sells

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$726M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$562M
3
MSFT icon
Microsoft
MSFT
+$557M
4
PSX icon
Phillips 66
PSX
+$548M
5
BA icon
Boeing
BA
+$465M

Sector Composition

Rank Sector Weight
1 Technology 16.49%
2 Financials 10%
3 Healthcare 7.03%
4 Consumer Discretionary 6.75%
5 Industrials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMX icon
8301
Immix Biopharma
IMMX
$581M
$17K ﹤0.01%
10,121
-4,087
-29% -$7.71K
FEDM icon
8302
FlexShares ESG & Climate Developed Markets ex-US Core Index Fund
FEDM
$79M
$17K ﹤0.01%
+335
New +$16.9K
SBXD.U
8303
SilverBox Corp IV Units
SBXD.U
$17K ﹤0.01%
+1,650
New +$17K
ENZ
8304
DELISTED
Enzo Biochem, Inc.
ENZ
$16.9K ﹤0.01%
45,713
+45,435
+16,344% +$25.1K
LBAY icon
8305
Leatherback Long/Short Alternative Yield ETF
LBAY
$18.4M
$16.9K ﹤0.01%
655
+127
+24% +$3.13K
NVVE
8306
DELISTED
Nuvve Holding Corp
NVVE
$16.8K ﹤0.01%
+15
New +$26.4K
EART
8307
Global X Rare Earth & Critical Materials ETF
EART
$39.1M
$16.8K ﹤0.01%
1,162
+180
+18% +$2.69K
BCAB icon
8308
BioAtla
BCAB
$5.66M
$16.8K ﹤0.01%
967
-50
-5% -$1.07K
LOAN
8309
Manhattan Bridge Capital
LOAN
$48.7M
$16.8K ﹤0.01%
2,838
+2,502
+745% +$14.1K
FTH
8310
Faeth Therapeutics
FTH
$712M
$16.8K ﹤0.01%
+2,127
New +$20.2K
OPAD icon
8311
Offerpad Solutions
OPAD
$19.4M
$16.7K ﹤0.01%
1,008
-101
-9% -$2.2K
DIST
8312
DELISTED
Distoken Acquisition Corp
DIST
$16.7K ﹤0.01%
1,504
+1,004
+201% +$11.5K
ULVM icon
8313
VictoryShares US Value Momentum ETF
ULVM
$267M
$16.7K ﹤0.01%
+208
New +$17.1K
DHSB
8314
Day Hagan Smart Buffer ETF
DHSB
$38.4M
$16.7K ﹤0.01%
+683
New +$16.9K
DMAC icon
8315
DiaMedica Therapeutics
DMAC
$344M
$16.6K ﹤0.01%
4,382
+2,613
+148% +$14.9K
TINY icon
8316
ProShares Nanotechnology ETF
TINY
$17.1M
$16.6K ﹤0.01%
440
+409
+1,319% +$18K
NVNI
8317
Nvni Group
NVNI
$12.4M
$16.5K ﹤0.01%
7,723
+5,003
+184% +$108K
HYKE
8318
DELISTED
Vest 2 Year Interest Rate Hedge ETF
HYKE
$16.5K ﹤0.01%
653
JHID icon
8319
John Hancock International High Dividend ETF
JHID
$11.3M
$16.5K ﹤0.01%
540
-1
-0.2% -$30
RMTI icon
8320
Rockwell Medical
RMTI
$29.5M
$16.5K ﹤0.01%
1,460
-561
-28% -$10.2K
ZTS icon
8321
PUT
Zoetis
ZTS
$32.5B
$16.5K ﹤0.01%
100
-95,000
-100% -$15.8M
RGEF
8322
Rockefeller Global Equity ETF
RGEF
$810M
$16.5K ﹤0.01%
649
IOPP icon
8323
Simplify Tara India Opportunities ETF
IOPP
$7.42M
$16.4K ﹤0.01%
660
+274
+71% +$6.79K
GFLW
8324
VictoryShares Free Cash Flow Growth ETF
GFLW
$897M
$16.4K ﹤0.01%
+755
New +$18.1K
VAL.WS icon
8325
Valaris Ltd Warrants
VAL.WS
$631M
$16.3K ﹤0.01%
3,210
+1,109
+53% +$7.05K

Similar funds

UBS Group's Q1 2025 Portfolio in Review

As of Q1 2025, UBS Group held 11,092 positions worth $544B, up 0.53% from $541B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $24.2B of net new capital in Q1 2025, opening 1,200 new positions and adding to 4,608 existing holdings. Its largest new stake was Sandisk: 3,424,800 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Strategy Inc, an estimated $726M trimmed.

  • UBS Group's largest Q1 2025 buy was Sandisk: 3,424,800 shares worth $163M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $1.64B increase.
  • UBS Group's biggest Q1 2025 reduction was Strategy Inc, cutting an estimated $726M.
  • UBS Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $432M.
  • UBS Group's ten largest holdings make up 14% of its $544B portfolio in Q1 2025.
  • UBS Group opened 1,200 new positions and closed 929 in Q1 2025.
  • UBS Group's portfolio value rose 0.53% quarter-over-quarter to $544B.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.